Financial statements Apteopharm Spółka Z Ograniczoną Odpowiedzialnością
Balance sheet data of APTEOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Year
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 4 759 128,71 | 4 921 114,88 | 6 267 494,31 | 6 531 119,38 |
A. Fixed assets | 400 341,06 | 244 900,51 | 174 443,79 | 139 434,94 |
B. Current assets | 4 358 787,65 | 4 676 214,37 | 6 093 050,52 | 6 391 684,44 |
C. Share capital contributions (basic funds) | - | - | - | - |
D. Own shares (stocks) | - | - | - | - |
Total liabilities | 4 759 128,71 | 4 921 114,88 | 6 267 494,31 | 6 531 119,38 |
A. Equity | 1 751 720,63 | 2 179 027,87 | 3 027 147,74 | 2 397 461,32 |
B. Liabilities and provisions for liabilities | 3 007 408,08 | 2 742 087,01 | 3 240 346,57 | 4 133 658,06 |
I. Long-term liabilities | 326 105,46 | 108 701,46 | 0,00 | 0,00 |
II. Short-term liabilities | 2 223 502,34 | 2 608 281,79 | 3 210 843,13 | 3 990 805,11 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.